Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
about
Pain Prevention Using Head and Neck Cancer as a ModelMulti-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head anNomogram for predicting symptom severity during radiation therapy for head and neck cancer.Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot studyAssessment of cancer therapy-induced oral mucositis using a patient-reported oral mucositis experience questionnaire.Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis.Symptoms Reported by Head and Neck Cancer Patients during Radiotherapy and Association with Mucosal Ulceration Site and Size: An Observational StudyPharmacological protection from radiation ± cisplatin-induced oral mucositisJaw mobility changes in patients with upper aerodigestive tract cancer undergoing radiation therapy.Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinomaAcute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancerEffect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study.Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiationIdentifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer.Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.Evaluation of current and upcoming therapies in oral mucositis prevention.Oral cancers: supportive care issues.The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue.One-Year Swallowing Outcomes in Patients Treated with Prophylactic Gabapentin During Radiation-Based Treatment for Oropharyngeal Cancer.Effect of topical vasoconstrictor exposure upon tumoricidal radiotherapy.Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy.Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.A feasibility and efficacy trial of a hand-held humidification device in patients undergoing radiotherapy for head and neck cancer.Innovative intraoral cooling device better tolerated and equally effective as ice cooling.Changes of oral microcirculation in chemotherapy patients: A possible correlation with mucositis?Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation.Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma.Assessment of oral mucositis during concurrent chemoradiation of head and neck cancers using patient-reported measurement scale.Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.Cancer patients as frequent attenders in emergency departments: A national cohort study
P2860
Q26785727-D42333A4-EADD-4C39-B0AF-6B6E9351DF48Q34180799-92DFFF08-3686-4830-9F67-FCADA4DAE33FQ34287961-2384A6AA-6BBE-4886-8E4C-34F11D7C0051Q35006844-52790C26-AA53-49D2-891D-6894B1813E05Q35116385-F87FAAE5-F9E8-46EA-BCD4-4418C8447782Q35221603-9F9A9F2A-56D0-43EC-B52B-331AB57ADD70Q35659390-6BACB793-E6F8-4AC5-A17E-CC40D41E1739Q35857066-58647F86-198C-4FEE-BBB0-CBA2A80CFD45Q36348219-696620D9-48CA-4A06-94DF-071A457E6BB1Q36416296-4FFA68A9-121F-4070-9DD5-2BC092097C03Q36626509-91DE3190-3CA0-43AD-A0CF-859866A8B8FCQ36869034-44E17D58-9B3B-4CD1-9EF3-430D2E10DAEEQ37023430-C7BBE930-36A1-4E24-9037-178F434584ADQ37157775-74579D90-C042-49E6-A6BF-B4DAE39D93D8Q37438294-561485E5-522A-47A8-9DEA-99B6B4DE0579Q37640672-7A3573DD-2256-4C44-AD5D-4BFB45D33AE2Q37818225-E780410D-F67E-4227-B3A0-AF10FFD52158Q37903909-64CB3EFF-07C7-47A3-A4DA-8FF605B01469Q38130475-043E78EE-3F7C-435D-9453-EA331A8684C0Q38958612-B06B5B3B-34C7-4290-9F2C-5D01E16E82A2Q39029757-A67AC93F-755E-4446-B9BE-80E5F551FE9BQ39282386-CCFCDADC-3876-4505-963A-CD99A2153879Q40020541-44909DCE-6188-4C7D-81A1-E6FFDD4CEC0DQ40269202-9D56F204-EF2B-4CF7-B4A7-AB56A177FC00Q41991411-3A99609D-6CBF-4DB9-8B58-9B47E2D8A113Q43499959-2F181856-A352-4D4D-A999-38BD58275BA9Q44765770-B1911908-92B0-4260-9015-CDD4CA48AD5EQ48235262-F3A0984C-C6F6-4F9C-A7B3-4171248A6157Q55119896-50FC8D82-A666-441C-9A9C-827EF5EB7730Q55280611-334894AA-B5D1-4C04-8621-EB818D9F9B35Q58767687-11EA3883-2FDE-468F-8705-6B441FC15A6F
P2860
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Mucositis-related morbidity an ...... with or without chemotherapy.
@en
Mucositis-related morbidity an ...... with or without chemotherapy.
@nl
type
label
Mucositis-related morbidity an ...... with or without chemotherapy.
@en
Mucositis-related morbidity an ...... with or without chemotherapy.
@nl
prefLabel
Mucositis-related morbidity an ...... with or without chemotherapy.
@en
Mucositis-related morbidity an ...... with or without chemotherapy.
@nl
P2093
P1476
Mucositis-related morbidity an ...... with or without chemotherapy.
@en
P2093
Adam S Garden
Andy M Trotti
Barbara A Murphy
Clement K Gwede
David M Brizel
Jennifer L Beaumont
Joel B Epstein
John Isitt
Lisa A Bellm
Nancy Wells
P304
P356
10.1016/J.JPAINSYMMAN.2008.12.004
P50
P577
2009-07-15T00:00:00Z